Jennifer Rose Gatchel, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 24 | 2023 | 7988 | 1.700 |
Why?
|
| Amyloid beta-Peptides | 15 | 2023 | 3574 | 0.940 |
Why?
|
| Apathy | 3 | 2022 | 96 | 0.890 |
Why?
|
| Presenilin-1 | 6 | 2023 | 635 | 0.780 |
Why?
|
| tau Proteins | 11 | 2023 | 1860 | 0.650 |
Why?
|
| Entorhinal Cortex | 3 | 2023 | 264 | 0.600 |
Why?
|
| Geriatric Psychiatry | 2 | 2023 | 70 | 0.530 |
Why?
|
| Neurosyphilis | 1 | 2015 | 22 | 0.520 |
Why?
|
| Depression | 7 | 2023 | 7733 | 0.520 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 2 | 2019 | 26 | 0.490 |
Why?
|
| Amyloidosis | 1 | 2020 | 795 | 0.470 |
Why?
|
| Temporal Lobe | 3 | 2019 | 1669 | 0.460 |
Why?
|
| Spinocerebellar Ataxias | 3 | 2008 | 88 | 0.440 |
Why?
|
| Mental Disorders | 4 | 2023 | 6587 | 0.430 |
Why?
|
| Antipsychotic Agents | 2 | 2023 | 3058 | 0.410 |
Why?
|
| Amyloid | 4 | 2023 | 795 | 0.410 |
Why?
|
| Parietal Lobe | 1 | 2017 | 837 | 0.400 |
Why?
|
| Positron-Emission Tomography | 20 | 2023 | 6259 | 0.360 |
Why?
|
| Agnosia | 2 | 2020 | 66 | 0.360 |
Why?
|
| Neuropsychological Tests | 11 | 2022 | 6974 | 0.360 |
Why?
|
| Memory Disorders | 3 | 2020 | 1183 | 0.320 |
Why?
|
| Somatomedins | 1 | 2008 | 192 | 0.300 |
Why?
|
| Aniline Compounds | 7 | 2021 | 983 | 0.280 |
Why?
|
| Cognition Disorders | 2 | 2019 | 4030 | 0.280 |
Why?
|
| Independent Living | 2 | 2021 | 564 | 0.270 |
Why?
|
| Tauopathies | 2 | 2019 | 307 | 0.260 |
Why?
|
| DNA Repeat Expansion | 1 | 2005 | 66 | 0.260 |
Why?
|
| Brain Diseases | 1 | 2014 | 1554 | 0.260 |
Why?
|
| Brain | 12 | 2023 | 26343 | 0.250 |
Why?
|
| Aged | 31 | 2023 | 162944 | 0.230 |
Why?
|
| Ethylene Glycols | 3 | 2021 | 156 | 0.220 |
Why?
|
| Bipolar Disorder | 4 | 2022 | 5024 | 0.220 |
Why?
|
| Behavioral Symptoms | 1 | 2023 | 175 | 0.210 |
Why?
|
| Activities of Daily Living | 3 | 2023 | 2414 | 0.200 |
Why?
|
| Longitudinal Studies | 9 | 2020 | 13921 | 0.200 |
Why?
|
| Anxiety | 3 | 2023 | 4279 | 0.200 |
Why?
|
| Genomic Instability | 1 | 2005 | 695 | 0.200 |
Why?
|
| Thiazoles | 5 | 2019 | 1484 | 0.180 |
Why?
|
| Aging | 4 | 2023 | 8626 | 0.180 |
Why?
|
| Hippocampus | 4 | 2023 | 3661 | 0.180 |
Why?
|
| Colombia | 4 | 2021 | 259 | 0.180 |
Why?
|
| Cognition | 5 | 2023 | 6722 | 0.170 |
Why?
|
| Self Report | 2 | 2021 | 3548 | 0.170 |
Why?
|
| Neurofilament Proteins | 1 | 2021 | 318 | 0.170 |
Why?
|
| Humans | 50 | 2023 | 742088 | 0.160 |
Why?
|
| Heterozygote | 3 | 2021 | 2790 | 0.160 |
Why?
|
| Aged, 80 and over | 14 | 2023 | 57683 | 0.160 |
Why?
|
| Psychological Techniques | 1 | 2017 | 45 | 0.160 |
Why?
|
| Euphoria | 1 | 2017 | 67 | 0.150 |
Why?
|
| Psychotic Disorders | 2 | 2022 | 3040 | 0.150 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 24913 | 0.140 |
Why?
|
| Mental Health | 2 | 2023 | 2997 | 0.140 |
Why?
|
| Cerebellum | 3 | 2013 | 1490 | 0.140 |
Why?
|
| Irritable Mood | 1 | 2017 | 183 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 4 | 2011 | 4465 | 0.130 |
Why?
|
| Dementia | 2 | 2022 | 2501 | 0.130 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2015 | 35 | 0.130 |
Why?
|
| Electroconvulsive Therapy | 1 | 2020 | 472 | 0.130 |
Why?
|
| Mutation | 5 | 2023 | 29717 | 0.130 |
Why?
|
| Psychosomatic Medicine | 1 | 2015 | 75 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2005 | 1617 | 0.130 |
Why?
|
| Malnutrition | 1 | 2021 | 625 | 0.120 |
Why?
|
| Male | 29 | 2023 | 349538 | 0.120 |
Why?
|
| Female | 29 | 2023 | 379592 | 0.110 |
Why?
|
| Syphilis | 1 | 2015 | 226 | 0.110 |
Why?
|
| Corpus Striatum | 1 | 2019 | 1220 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2018 | 6030 | 0.110 |
Why?
|
| Antigens, Ly | 1 | 2013 | 291 | 0.110 |
Why?
|
| Asymptomatic Diseases | 3 | 2019 | 552 | 0.100 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2011 | 147 | 0.090 |
Why?
|
| Radiopharmaceuticals | 2 | 2019 | 2658 | 0.090 |
Why?
|
| Lithium | 1 | 2013 | 601 | 0.090 |
Why?
|
| Hallucinations | 2 | 2022 | 360 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2023 | 4282 | 0.080 |
Why?
|
| Nuclear Proteins | 3 | 2008 | 5851 | 0.080 |
Why?
|
| Middle Aged | 13 | 2023 | 213127 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 2838 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2023 | 8297 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2017 | 2013 | 0.080 |
Why?
|
| Psychometrics | 1 | 2017 | 2999 | 0.080 |
Why?
|
| Alleles | 1 | 2019 | 6931 | 0.080 |
Why?
|
| Carbolines | 2 | 2019 | 265 | 0.080 |
Why?
|
| Retinal Degeneration | 1 | 2011 | 414 | 0.070 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2008 | 242 | 0.070 |
Why?
|
| Purkinje Cells | 1 | 2008 | 223 | 0.070 |
Why?
|
| Atrophy | 2 | 2023 | 1576 | 0.070 |
Why?
|
| Metabolome | 1 | 2013 | 881 | 0.070 |
Why?
|
| Lithium Carbonate | 1 | 2007 | 184 | 0.070 |
Why?
|
| Affective Symptoms | 2 | 2021 | 407 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2019 | 5095 | 0.070 |
Why?
|
| Depressive Disorder | 1 | 2019 | 3748 | 0.070 |
Why?
|
| Life Style | 1 | 2017 | 3824 | 0.070 |
Why?
|
| Forecasting | 1 | 2014 | 2948 | 0.060 |
Why?
|
| Myotonic Dystrophy | 1 | 2005 | 78 | 0.060 |
Why?
|
| Friedreich Ataxia | 1 | 2005 | 76 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2008 | 23387 | 0.060 |
Why?
|
| Tobacco necrosis satellite virus | 1 | 2004 | 1 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1866 | 0.060 |
Why?
|
| Fragile X Syndrome | 1 | 2005 | 115 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-4F | 1 | 2004 | 41 | 0.060 |
Why?
|
| Education, Medical | 1 | 2015 | 1717 | 0.060 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2004 | 141 | 0.060 |
Why?
|
| Rheumatic Fever | 1 | 2003 | 71 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 18006 | 0.060 |
Why?
|
| Antimanic Agents | 1 | 2007 | 522 | 0.060 |
Why?
|
| Disease Progression | 4 | 2023 | 13256 | 0.060 |
Why?
|
| Schizophrenia | 1 | 2022 | 6874 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2020 | 4628 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 494 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2020 | 12695 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 12730 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2023 | 151 | 0.050 |
Why?
|
| Sleep | 1 | 2017 | 4604 | 0.050 |
Why?
|
| Personality Tests | 1 | 2021 | 83 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2004 | 562 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 17400 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2008 | 3001 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12958 | 0.040 |
Why?
|
| Potassium | 1 | 2004 | 1336 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2008 | 12071 | 0.040 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 69 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2008 | 9735 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2003 | 1538 | 0.040 |
Why?
|
| Life Change Events | 1 | 2023 | 937 | 0.040 |
Why?
|
| Spouses | 1 | 2021 | 284 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2005 | 4013 | 0.040 |
Why?
|
| Risk | 2 | 2020 | 9679 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 21821 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2021 | 40450 | 0.040 |
Why?
|
| Neurodegenerative Diseases | 1 | 2005 | 1060 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 2126 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7873 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2023 | 2633 | 0.030 |
Why?
|
| Semantics | 1 | 2019 | 584 | 0.030 |
Why?
|
| Contrast Media | 2 | 2019 | 5295 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 72145 | 0.030 |
Why?
|
| Adult | 6 | 2021 | 213712 | 0.030 |
Why?
|
| RNA | 1 | 2005 | 2747 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 972 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2003 | 1636 | 0.030 |
Why?
|
| Algorithms | 1 | 2015 | 13853 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1107 | 0.030 |
Why?
|
| Brazil | 1 | 2018 | 1263 | 0.030 |
Why?
|
| Peptides | 1 | 2005 | 4392 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 15108 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2425 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 361 | 0.030 |
Why?
|
| Demography | 1 | 2017 | 1650 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2008 | 3731 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2021 | 1606 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 35342 | 0.030 |
Why?
|
| Mice | 5 | 2013 | 81045 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2022 | 2585 | 0.020 |
Why?
|
| Teaching Rounds | 1 | 2015 | 253 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2017 | 1146 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2017 | 1438 | 0.020 |
Why?
|
| Trinucleotide Repeats | 1 | 2011 | 261 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2021 | 2575 | 0.020 |
Why?
|
| Calcium | 1 | 2003 | 5753 | 0.020 |
Why?
|
| Caregivers | 1 | 2022 | 2074 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 1369 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3639 | 0.020 |
Why?
|
| Animals | 7 | 2013 | 168561 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 2146 | 0.020 |
Why?
|
| Linear Models | 1 | 2019 | 5948 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 2304 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3294 | 0.020 |
Why?
|
| Boston | 1 | 2021 | 9305 | 0.020 |
Why?
|
| Teaching | 1 | 2015 | 1174 | 0.020 |
Why?
|
| Protein Methyltransferases | 1 | 2007 | 55 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2007 | 126 | 0.020 |
Why?
|
| Sex Factors | 1 | 2021 | 10392 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2023 | 53187 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 898 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 2892 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2008 | 365 | 0.020 |
Why?
|
| Base Sequence | 2 | 2011 | 12797 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 12946 | 0.020 |
Why?
|
| Learning | 1 | 2015 | 1705 | 0.020 |
Why?
|
| Proteomics | 1 | 2019 | 3618 | 0.020 |
Why?
|
| Emotions | 1 | 2017 | 2657 | 0.020 |
Why?
|
| Glutamine | 1 | 2008 | 574 | 0.020 |
Why?
|
| Maze Learning | 1 | 2007 | 478 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2020 | 6540 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2007 | 430 | 0.020 |
Why?
|
| Registries | 1 | 2020 | 8077 | 0.020 |
Why?
|
| Metabolomics | 1 | 2013 | 1467 | 0.020 |
Why?
|
| Neurons | 1 | 2004 | 9325 | 0.020 |
Why?
|
| Shal Potassium Channels | 1 | 2004 | 21 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2007 | 8436 | 0.020 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2004 | 56 | 0.020 |
Why?
|
| United States | 2 | 2023 | 69693 | 0.020 |
Why?
|
| Dendrites | 1 | 2007 | 485 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 2751 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2019 | 6142 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2004 | 173 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 829 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 464 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2003 | 428 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2088 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9144 | 0.010 |
Why?
|
| Xenopus | 1 | 2004 | 712 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 6171 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 508 | 0.010 |
Why?
|
| Time Factors | 2 | 2017 | 40054 | 0.010 |
Why?
|
| Pyramidal Cells | 1 | 2004 | 363 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 963 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8328 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18355 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 1723 | 0.010 |
Why?
|
| Ribosomes | 1 | 2004 | 499 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2004 | 914 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 2471 | 0.010 |
Why?
|
| Transfection | 1 | 2008 | 5892 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2004 | 1263 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2003 | 621 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 15494 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 1081 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 3504 | 0.010 |
Why?
|
| Oocytes | 1 | 2004 | 1186 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 1059 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 1224 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 2502 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14554 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2723 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2004 | 19223 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23320 | 0.010 |
Why?
|
| Memory | 1 | 2007 | 2163 | 0.010 |
Why?
|
| Hypertension | 1 | 2017 | 8455 | 0.010 |
Why?
|
| Rats | 2 | 2004 | 24265 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 2714 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 3770 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2004 | 2899 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 4211 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 62966 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 8300 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2004 | 3020 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 56350 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 13029 | 0.010 |
Why?
|
| Child | 1 | 2019 | 77478 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 18112 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 85649 | 0.010 |
Why?
|